![]() | Up a level |
Carvajal, Richard D, Butler, Marcus O, Shoushtari, Alexander N, Hassel, Jessica C, Ikeguchi, Alexandra, Hernandez-Aya, Leonel, Nathan, Paul, Hamid, Omid, Piulats, Josep M, Rioth, Matthew et al (show 11 more authors)
(2022)
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.
Nature Medicine, 28 (11).
2364-+.
Nathan, Paul, Hassel, Jessica C, Rutkowski, Piotr, Baurain, Jean-Francois, Butler, Marcus O, Schlaak, Max, Sullivan, Ryan J, Ochsenreither, Sebastian, Dummer, Reinhard, Kirkwood, John M et al (show 18 more authors)
(2021)
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
NEW ENGLAND JOURNAL OF MEDICINE, 385 (13).
pp. 1196-1206.
Carvajal, Richard D, Nathan, Paul, Sacco, Joseph J, Orloff, Marlana, Hernandez-Aya, Leonel F, Yang, Jessica, Luke, Jason J, Butler, Marcus O, Stanhope, Sarah, Collins, Laura et al (show 4 more authors)
(2022)
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma.
Journal of Clinical Oncology, 40 (17).
1939-+.